Syquant Capital SAS Portfolio holdings
Top Buys
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$69.6M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$58.6M |
| 3 |
Capri Holdings
CPRI
|
+$5.15M |
| 4 |
TWNK
Hostess Brands, Inc. Class A Common Stock
TWNK
|
+$4.9M |
| 5 |
NATI
National Instruments Corp
NATI
|
+$3.13M |
Top Sells
Sector Composition
| 1 | Healthcare | 64.41% |
| 2 | Technology | 29.3% |
| 3 | Consumer Discretionary | 2.66% |
| 4 | Consumer Staples | 2.39% |
| 5 | Industrials | 0.47% |
Similar funds
Syquant Capital SAS's Q3 2023 Portfolio in Review
As of Q3 2023, Syquant Capital SAS held 19 positions worth $255M, up 85% from $138M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Syquant Capital SAS deployed $96.5M of net new capital in Q3 2023, opening 7 new positions and adding to 1 existing holding. Its largest new stake was Activision Blizzard: 763,211 shares worth $71.5M.
By sector, the portfolio is most concentrated in Healthcare at 64% of assets, down from 75% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the most notable exit was IVERIC bio, Inc. Common Stock, an estimated $16M sold.
- Syquant Capital SAS's largest Q3 2023 buy was Activision Blizzard: 763,211 shares worth $71.5M.
- Syquant Capital SAS added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2023, an estimated $58.6M increase.
- Syquant Capital SAS fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $16M.
- Syquant Capital SAS's ten largest holdings make up 100% of its $255M portfolio in Q3 2023.
- Syquant Capital SAS opened 7 new positions and closed 10 in Q3 2023.
- Syquant Capital SAS's portfolio value rose 85% quarter-over-quarter to $255M.
Based on Syquant Capital SAS's 13F filing for Q3 2023, filed 12 Oct 2023.